Akari Therapeutics Plc (AKTX)
↓ Download CSVKey ratios (FY2025)
-61.1%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$17.27M | -$21.64M | -$16.81M | -$23.09M | -$17.21M | -$17.98M | -$16.96M | -$20.79M | -$37.78M | -$27.25M |
| Net Income | -$17.30M | -$19.79M | -$10.01M | -$17.75M | -$17.42M | -$17.08M | -$16.85M | -$20.50M | -$35.40M | -$18.14M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | — | — | — |
| Total Assets | $47.89M | $50.56M | $4.36M | $13.83M | $11.65M | $14.60M | $6.48M | $8.03M | $29.05M | $45.87M |
| Total Liabilities | $19.56M | $28.33M | $4.58M | $12.04M | $6.09M | $5.22M | $6.47M | $4.92M | $11.90M | $11.77M |
| Shareholders' Equity | $28.33M | $22.23M | -$229.0K | $1.79M | $5.55M | $9.38M | $7.6K | $4.37M | $22.24M | $34.10M |
| Cash & Equivalents | $0 | $0 | $3.85M | $13.25M | $9.36M | $14.06M | $5.73M | $5.45M | $28.11M | $34.10M |
| Operating Cash Flow | -$10.57M | -$12.55M | -$16.43M | -$21.50M | -$18.85M | -$16.95M | -$12.92M | -$22.77M | -$31.60M | -$24.62M |
| Capital Expenditures | — | — | — | — | — | — | $0 | $0 | $36.9K | $54.8K |
| Shares Outstanding | 90.54B | 53.19B | 13.23B | 7.44B | 4.76B | 3.85B | 2.25B | 312.0K | 1.53B | 1.18B |